Conference Material
|
Slide Presentation
Pregnancy outcomes in patients undergoing drug-resistant tuberculosis treatment in two closely monitored cohorts
Lachenal N,
Hewison CCH,
Berry C,
Mitnick CD,
Ahmed SM,
Osso E,
Bastard M,
Kazounis E,
Motta I,
Nyang'wa BT
View HTML
View PDF
Share
Download
Download
View PDF
Share
Countries
Kazakhstan
Pakistan
Uzbekistan
Subject Area
antibiotic resistance
tuberculosis
women's health
neonatal health
antimicrobial resistance
Collections
New tools and approaches to drug-resistant TB
Languages
English
DOI
10.57740/a29q-eq28
Published Date
11 May 2022
Conference
MSF Scientific Days International 2022
Linked Content
Conference Material
|
Abstract
Pregnancy outcomes in patients undergoing drug-resistant tuberculosis treatment in two closely monitored cohorts
2022 May 11 • MSF Scientific Days International 2022
Conference Material
|
Video
Pregnancy outcomes in patients undergoing drug-resistant tuberculosis treatment in two closely monitored cohorts
2022 June 10 • MSF Scientific Days International 2022
Similar Content
Abstract
|
Abstract
Pregnancy outcomes in patients undergoing drug-resistant tuberculosis treatment in two closely monitored cohorts
2022 May 11 • MSF Scientific Days International 2022
Video
|
Video
Pregnancy outcomes in patients undergoing drug-resistant tuberculosis treatment in two closely monitored cohorts
2022 June 10 • MSF Scientific Days International 2022
Loading...